From: Leishmaniasis and glycosaminoglycans: a future therapeutic strategy?
Physiological function | Heparin | Heparan sulfate | Chondroitin sulfate | Dermatan sulfate | Hyaluronic acid | Keratan sulfate |
---|---|---|---|---|---|---|
Cell-cell/cell-matrix interactions | – | Thakar et al. [54] | Milstone et al. [58] | Lewandowska et al. [63] | Underhill et al. [67] | Funderburgh et al. [72] |
Immune modulation | Almeida et al. [50] Borsig et al. [51] | Almeida et al. [50]; Thakar et al. [54] | Borsig et al. [51] | Nadafi et al. [64] | Horton et al. [68]; Termeer et al. [69] | Leroux et al. [73] |
Host-pathogen interactions | Angeletti et al. [52] | Takemae et al. [55]; Ndonwi et al. [56] | Rogerson et al. [59]; Ayres Pereira et al. [60] | Ndonwi et al. [56]; Fortune et al. [65] | Beeson et al. [70] Skinsnes et al. [71] | – |
Anticoagulant activities | McLean et al. [53] | Shworak et al. [57] | Mourão et al. [61]; Glauser et al. [62] | Ofosu et al. [66] | – | – |